Katia Karalis

Company: Regeneron Pharmaceuticals Inc

Job title: Executive Director

Seminars:

Implementing Genetic Findings to Drug Development Through Microphysiological Systems & In Vivo Methods 4:00 pm

Assessing how genetic variants impact the MoA of obesity Investigating the use of microphysiological systems for novel obesity therapeutic development Manipulating multicellular organoids to replicate human level models for obesity, liver disease and NASHRead more

day: Conference Day One